The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivoNATURE COMMUNICATIONSIF15.72024-08-012OAAI
Molecular Basis for Antiviral Action of EDP-235: A Potent and Selective SARS-CoV-2 3CLpro Inhibitor for the Treatment of Covid 19FASEB JOURNALIF4.22022-05-135OA
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorSCIENTIFIC REPORTSIF3.92019-12-279OAAI
The wide utility of rabbits as models of human diseases (vol 50, 66, 2018)EXPERIMENTAL AND MOLECULAR MEDICINEIF12.92019-07-041OAAI
EDP-514, a novel HBV core inhibitor with potent antiviral activity both in vitro and in vivoJOURNAL OF HEPATOLOGYIF332019-04-0113PREAI
Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor bindingEMERGING MICROBES & INFECTIONSIF7.52019-01-2514OAAI
The wide utility of rabbits as models of human diseasesEXPERIMENTAL AND MOLECULAR MEDICINEIF12.92018-05-22123OAAI
Discovery of a novel core inhibitor EP-027367 with potent antiviral activity both in vitro and in a humanized mouse modelJOURNAL OF HEPATOLOGYIF332018-04-012PREAI
Application of replication-defective West Nile virus vector to non-flavivirus vaccine targetsHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52017-09-193OAAI
A Novel Rabbit Monoclonal Antibody Platform To Dissect the Diverse Repertoire of Antibody Epitopes for HIV-1 Env Immunogen DesignJOURNAL OF VIROLOGYIF3.82013-09-1533OAAI
Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected HumansJOURNAL OF VIROLOGYIF3.82013-09-1543OAAI
Two Closely Related Env Antigens from the Same Patient Elicited Different Spectra of Neutralizing Antibodies against Heterologous HIV-1 IsolatesJOURNAL OF VIROLOGYIF3.82011-05-1514OAAI
Progress on the Induction of Neutralizing Antibodies Against HIV Type 1 (HIV-1)BIODRUGSIF6.92009-06-0110OAAI
Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccinationJOURNAL OF VIROLOGYIF3.82008-08-0191OAAI